pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,256 catalysts · 5,256 phase readout · 2,308 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 37 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout5,256
  • 8k filing2,308
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT04662255: Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

Sponsor: Loxo Oncology, Inc.. Phase: PHASE3. Conditions: Lymphoma, Mantle-Cell

full page →ctgov ↗
›RECRUITINGphase readoutNCT06077643: Workshops and Exchange Groups for Laryngectomized Patients

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Laryngectomy; Status, Laryngeal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04936308: Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent

Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Arthritis, Psoriatic

full page →ctgov ↗
›RECRUITINGphase readoutNCT07571317: Combined Predictive Value of RSBI and CALLY Index in Predicting Weaning Success in ICU Patients

Sponsor: Istanbul University - Cerrahpasa. Phase: . Conditions: Critical Illness, Respiratory Insufficiency, Ventilator Weaning, Weaning Failure of Mechanical Ventilation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07164040: Leica Microsystems Sponsored Study to Collect and Confirm Clinical Data on the Performance of the GLOW800 Device When Used in Accordance With Its Intended Use.

Sponsor: Leica Microsystems (Schweiz) AG. Phase: . Conditions: Reconstructive Surgical Procedures, Plastic Surgery, Vascular Surgical Procedure, Cerebrovascular Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07361640: DiaMester Pilot RCT: E-health Lifestyle Program for Type 2 Diabetes

Sponsor: Oslo University Hospital. Phase: NA. Conditions: Diabetes Mellitus, Type 2

full page →ctgov ↗
›COMPLETEDphase readoutNCT03981289: Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)

Sponsor: Virginia Commonwealth University. Phase: . Conditions: Limb Girdle Muscular Dystrophy, Muscular Dystrophies

full page →ctgov ↗
›RECRUITINGphase readoutNCT07510789: Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis

Sponsor: Konya Beyhekim Training and Research Hospital. Phase: . Conditions: Ankylosing Spondylitis, Low Back Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01907789: Prophylactic Salpingectomy With Delayed Oophorectomy

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Ovarian Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07090291: China Colorectal Cancer Screening Trial 1 (C-Cost1)

Sponsor: Zhejiang University. Phase: NA. Conditions: Colorectal Cancer, Advanced Adenoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07307690: 8 Weeks vs 12 Weeks Physical Exercise Programmes in Colorectal Cancer Patients

Sponsor: University of Salamanca. Phase: NA. Conditions: Oncology, Chemotherapy-Induced Peripheral Neuropathy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07463690: Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer

Sponsor: Sun Yat-sen University. Phase: NA. Conditions: Colorectal Cancer, Stoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07604597: A Digital Stewardship Strategy for Patients With Reported Penicillin Allergy

Sponsor: Althaia Xarxa Assistencial Universitària de Manresa. Phase: . Conditions: Penicillin Allergy, In-hospital Process Optimization

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05757713: Teplizumab in Pediatric Stage 2 Type 1 Diabetes

Sponsor: Sanofi. Phase: PHASE4. Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›RECRUITINGphase readoutNCT07268560: Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE

Sponsor: Sir Run Run Shaw Hospital. Phase: . Conditions: Complicated Intra-Abdominal Infections, cIAIs, Hospital-acquired Pneumonia (HAP), Ventilator-Associated Pneumonia (VAP)

full page →ctgov ↗
›WITHHELDphase readoutNCT05479513: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07437313: Marine Lipids Ease Painful TMD

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Temporomandibular Disorder (TMD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07034313: Rouen Study on Anxiety

Sponsor: University Hospital, Rouen. Phase: . Conditions: Anxiety Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07198282: The Effect of Different Flap Closure Techniques on Postoperative Morbidity in Impacted Third Molar Surgery

Sponsor: Recep Tayyip Erdogan University. Phase: NA. Conditions: Impacted Mandibular Third Molar, Postoperative Morbidity, Oral Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT06238882: Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.

Sponsor: Instituto Nacional de Cancerologia de Mexico. Phase: NA. Conditions: Non-small Cell Lung Cancer, Brain Metastases, EGFR Gene Mutation

full page →ctgov ↗
›COMPLETEDphase readoutNCT07389382: The Effectiveness of the Three-dimensional Biochemical Activity Model of Pain

Sponsor: Zonguldak Bulent Ecevit University. Phase: NA. Conditions: Pain Management, 3D Printing, Education Nursing

full page →ctgov ↗
›RECRUITINGphase readoutNCT06163482: Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis

Sponsor: University of Cincinnati. Phase: EARLY_PHASE1. Conditions: Cystic Fibrosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07609693: The Relationship Between Oxytocin Massage in Mothers With Insufficient Milk Production in the Early Postpartum Period and Breastfeeding Self-Efficacy and Milk Let-down Reflex: A Randomized Controlled Study

Sponsor: Tokat Gaziosmanpasa University. Phase: NA. Conditions: Lactation Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT06093893: Hypotensive Anesthesia for Orthognathic Surgery

Sponsor: Boston Medical Center. Phase: PHASE4. Conditions: Hypotensive Anesthesia, Orthognathic Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT02344121: Intra- and Inter-fraction Changes in Radiation Therapy

Sponsor: Medical College of Wisconsin. Phase: . Conditions: Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT01987921: Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes

Sponsor: Children's Hospital Medical Center, Cincinnati. Phase: . Conditions: Acute Kidney Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT07457216: Visual and Patient-Reported Outcomes After Bilateral Non-Diffractive EDOF IOL Implantation

Sponsor: Benha University. Phase: NA. Conditions: Extended Depth-of-Focus Intraocular Lens, Cataract, Visual Acuity

full page →ctgov ↗
›COMPLETEDphase readoutNCT07521306: Biomarkers for Predicting Mortality in Patients With Suspected Sepsis

Sponsor: Antalya Training and Research Hospital. Phase: . Conditions: Sepsis, Mortality, Biomarkers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07190404: Multicontext Approach for Cognitive Function in Parkinson Disease

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: PARKINSON DISEASE (Disorder)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07542704: A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

Sponsor: Kumquat Biosciences Inc.. Phase: PHASE1. Conditions: Advanced Solid Tumors, Colorectal Cancer (CRC), Non-Small Cell Lung Cancer, Uterine Cancer, KRAS G12C Mutations, KRAS G12S Mutations

full page →ctgov ↗
›RECRUITINGphase readoutNCT05484804: Accountability for Care Through Undoing Racism & Equity for Moms

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Pregnancy Related, Maternal Health, Maternal Mortality, Low Birthweight, Racism, Implicit Bias

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03970304: CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated Adults

Sponsor: University of Maryland, Baltimore. Phase: PHASE4. Conditions: Typhoid Vaccination

full page →ctgov ↗
›COMPLETEDphase readoutNCT03867084: Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Hepatocellular Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04432584: A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Paroxysmal Nocturnal Hemoglobinuria

full page →ctgov ↗
›COMPLETEDphase readoutNCT04512547: Oxidative Stress in Asthma

Sponsor: Bastiaan Driehuys. Phase: PHASE2. Conditions: Asthma, Obesity

full page →ctgov ↗
›COMPLETEDphase readoutNCT07384247: Trigger Point Dry Needling With and Without Electrical Stimulation in Healthy Subjects

Sponsor: University of Rhode Island. Phase: NA. Conditions: People With Identified Painful Trigger Points (Tp) Within the Soleus and Gastrocnemius Muscles Complex, Healthy Subjects or Volunteers

full page →ctgov ↗
›WITHDRAWNphase readoutNCT03740347: Chronic Non-inflammatory Pains in Rheumatopediatrics

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Juvenile Idiopathic Arthritis

full page →ctgov ↗
›TERMINATEDphase readoutNCT03498638: Feasibility Study of Couple Therapy Treatment for Situational Couple Violence

Sponsor: University Hospitals Cleveland Medical Center. Phase: NA. Conditions: Violence, Domestic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07524049: Giving Children a Voice in Paediatric Anaesthesia

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: . Conditions: Perioperative Care, Pediatric Anesthesia, Pain Management, Anxiety, Research Agenda, Research Subjects

full page →ctgov ↗
›TERMINATEDphase readoutNCT03348748: Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer

Sponsor: Roswell Park Cancer Institute. Phase: EARLY_PHASE1. Conditions: Stage I Non-Small Cell Lung Cancer AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07380555: The Effectiveness and Safety of Artificial Intelligence(AI)-Assisted Medical Treatment Decision Support System Compared to Conventional Care in HFrEF Patients

Sponsor: Shanghai Zhongshan Hospital. Phase: NA. Conditions: Heart Failure With Reduced Ejection Fraction (HF-rEF)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05367635: A Study of SKB315 in Patients With Advanced Solid Tumors

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT02639325: Tumor Related Epilepsy

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: . Conditions: Epilepsy, Cancer, Brain Neoplasm

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05778825: A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Survivors of Childhood Cancer, Alopecia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06007976: LLLT to Reduce Low Back Pain

Sponsor: Mayo Clinic. Phase: NA. Conditions: Low Back Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06445140: Dynamics of Motivational Factors for Physical Activity and Nutrition in Oncogeriatrics

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: NA. Conditions: Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT02761889: Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer

Sponsor: Fundacao Champalimaud. Phase: NA. Conditions: Adenocarcinoma of the Prostate

full page →ctgov ↗
›RECRUITINGphase readoutNCT07500090: A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

Sponsor: Harmony Biosciences Management, Inc.. Phase: PHASE3. Conditions: Idiopathic Hypersomnia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07084090: Using IF-THEN Plans to Support Patients in Raising Safety Concerns About Their Care

Sponsor: University of Manchester. Phase: NA. Conditions: Patient Safety Concerns

full page →ctgov ↗
›RECRUITINGphase readoutNCT06118697: Feasibility of Aerodigestive Stimulation Therapy Trial

Sponsor: Sudarshan Jadcherla. Phase: NA. Conditions: Feeding Disorder Neonatal

full page →ctgov ↗
← prev
page 37 of 106
next →